A detailed history of Tekla Capital Management LLC transactions in Bicycle Therapeutics PLC stock. As of the latest transaction made, Tekla Capital Management LLC holds 44,338 shares of BCYC stock, worth $650,881. This represents 0.04% of its overall portfolio holdings.

Number of Shares
44,338
Previous 88,676 50.0%
Holding current value
$650,881
Previous $1.89 Million 40.03%
% of portfolio
0.04%
Previous 0.07%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023

SELL
$18.95 - $28.67 $840,205 - $1.27 Million
-44,338 Reduced 50.0%
44,338 $1.13 Million
Q3 2022

Nov 01, 2022

BUY
$17.49 - $28.44 $1.2 Million - $1.95 Million
68,611 Added 341.94%
88,676 $2.06 Million
Q2 2022

Jul 29, 2022

BUY
$12.95 - $46.99 $129,228 - $468,913
9,979 Added 98.94%
20,065 $337,000
Q1 2022

May 13, 2022

BUY
$40.12 - $59.5 $404,650 - $600,117
10,086 New
10,086 $443,000

Others Institutions Holding BCYC

About BICYCLE THERAPEUTICS plc


  • Ticker BCYC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,676,100
  • Market Cap $436M
  • Description
  • Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...
More about BCYC
Track This Portfolio

Track Tekla Capital Management LLC Portfolio

Follow Tekla Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tekla Capital Management LLC with notifications on news.